Furthermore, R-hirudin inhibited tumor growth, metastasis, and cell invasion by suppressing MMP9 expression, thereby inhibiting progression of non-small cell lung cancer, whose acute complications typically included APE (Zhao et al., 2022a). The gene discussed is MMP9; the disease is apparent mineralocorticoid excess.